Solid Biosciences

Solid Biosciences was founded by Ilan Ganot in 2013. Solid Biosciences is committed to treating Duchenne muscular dystrophy in multiple ways. The company’s leading gene therapy candidate, SGT-001, addresses the core issue of the disease by correcting the underlying mutations that cause Duchenne muscular dystrophy.